Home > Journals > Minerva Ortopedica e Traumatologica > Past Issues > Minerva Ortopedica e Traumatologica 2013 April;64(2) > Minerva Ortopedica e Traumatologica 2013 April;64(2):107-13

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ORTOPEDICA E TRAUMATOLOGICA

A Journal on Orthopedics and Traumatology


Official Journal of the Piedmontese-Ligurian-Lombard Society of Orthopedics and Traumatology
Indexed/Abtracted in: EMBASE, Scopus, Emerging Sources Citation Index


eTOC

 

  ORTHOPEDICS RESEARCH INNOVATIONS


Minerva Ortopedica e Traumatologica 2013 April;64(2):107-13

language: English

Cell-based therapies for regenerating bone

Goodman S. B.

Orthopaedic Research Laboratories, Stanford University, Stanford, CA, USA


PDF  


Cellular therapies to replenish bone lost due to acquired conditions such as trauma, infection, tumor, periprosthetic osteolysis and other etiologies have become widespread. Traditional, open, surgical bone grafting techniques have given way to newer cellular therapies that are potentially less invasive and have a lower complication rate and faster recovery time. These new technologies include bone marrow harvesting with concentration of osteoprogenitor cells with/without cell culture, scaffolds which are both osteoconductive and osteoinductive, attempts to facilitate mesenchymal stem cell and osteoprogenitor cell homing both locally and systemically, genetic engineering of specialized stem cells, and the use of potentially immune-privileged fetal and other types of stem cells. Some of these techniques have already been introduced into the orthopaedic clinic, whereas others are still in the pre-clinical testing phase. Given the limited supply of autologous graft, these new techniques will have a dramatic impact on bone regeneration in the future.

top of page

Publication History

Cite this article as

Corresponding author e-mail

goodbone@stanford.edu